Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I am happy to support H.R. 8333, the BIOSECURE Act. This bipartisan, bicameral bill prevents U.S. tax dollars from flowing to biotechnology companies that are owned, operated, and controlled by China or other foreign adversaries. Specifically, this bill names five genomic companies with direct ties to the Chinese Communist Party as biotechnology companies of concern. The bill then prohibits a Federal agency from procuring any biotechnology equipment or service from such companies. The bill also prohibits Federal loan or grant dollars from being used to procure, obtain, or use biotechnology equipment or services from such companies. The companies named in this legislation create significant risks to U.S. national security. BGI, one of the named entities, is a CCP biotechnology company and is the world's largest collector of genetic data. BGI, alongside its subsidiaries, which are also named in the bill, have been found to conduct research alongside the Chinese military. WuXi, through its two subsidiaries named in the bill, operates genetic testing centers established in coordination with the CCP, helps carry out research to promote the Chinese military, and has reportedly stolen U.S. firms' intellectual property.…
On the recordSeptember 9, 2024
Source
govinfo.govShare & report
More from James Comer
Mar 3, 2025
Mr. Speaker, I urge my colleagues to support this important legislation, which will streamline cybersecurity vulnerability disclosure to protect Federal IT systems. Mr. Speaker, I yield back the balance of my time. The SPEAKER pro tempore…
Jun 12, 2025
Despite President Trump's efforts to secure the border and enforce the law, Democrat-run sanctuary cities and states are siding with illegal aliens.
Jul 21, 2025
This raises an issue whether these pardons, whether these judicial appointments and whether these executive orders are legal.
Jul 12, 2025
There is no evidence, thus far, that has emerged that Joe Biden knew anything about who was using the autopen or the process involved in authorizing the use of the autopen.





